SI1379647T1 - Antagonist antiteles sesaläśevega citokina ali njegovega receptorja za zdravljenje alergije - Google Patents
Antagonist antiteles sesaläśevega citokina ali njegovega receptorja za zdravljenje alergijeInfo
- Publication number
- SI1379647T1 SI1379647T1 SI200131023T SI200131023T SI1379647T1 SI 1379647 T1 SI1379647 T1 SI 1379647T1 SI 200131023 T SI200131023 T SI 200131023T SI 200131023 T SI200131023 T SI 200131023T SI 1379647 T1 SI1379647 T1 SI 1379647T1
- Authority
- SI
- Slovenia
- Prior art keywords
- allergy
- receptor
- treatment
- antagonist antibodies
- mammalian cytokine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24721800P | 2000-11-10 | 2000-11-10 | |
US29826801P | 2001-06-14 | 2001-06-14 | |
EP01273862.1A EP1379647B1 (en) | 2000-11-10 | 2001-11-09 | Antagonist antibodies of a mammalian cytokine or its receptor for the treatment of allergy |
PCT/US2001/050351 WO2002068646A2 (en) | 2000-11-10 | 2001-11-09 | Mammalian cytokines; receptors; related reagents and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1379647T1 true SI1379647T1 (sl) | 2013-08-30 |
Family
ID=26938541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200131023T SI1379647T1 (sl) | 2000-11-10 | 2001-11-09 | Antagonist antiteles sesaläśevega citokina ali njegovega receptorja za zdravljenje alergije |
Country Status (7)
Country | Link |
---|---|
US (6) | US6890734B2 (sl) |
EP (2) | EP2292760A3 (sl) |
DK (1) | DK1379647T3 (sl) |
ES (1) | ES2424126T3 (sl) |
PT (1) | PT1379647E (sl) |
SI (1) | SI1379647T1 (sl) |
WO (1) | WO2002068646A2 (sl) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6982320B2 (en) | 1998-03-19 | 2006-01-03 | Human Genome Sciences, Inc. | Cytokine receptor common gamma chain like |
US6861227B2 (en) * | 1998-03-19 | 2005-03-01 | Human Genome Sciences, Inc. | Antibodies to cytokine receptor common gamma chain like |
US20030099947A1 (en) | 1998-09-21 | 2003-05-29 | Bazan J. Fernando | Mammalian cytokines; related reagents and methods |
US6890734B2 (en) * | 2000-11-10 | 2005-05-10 | Schering Corporation | Nucleic acids encoding a cytokine receptor complex |
US7379704B2 (en) * | 2001-10-10 | 2008-05-27 | Microsoft Corporation | Providing collaborative services with content |
DK2311869T3 (da) * | 2002-02-01 | 2013-03-18 | Merck Sharp & Dohme | Anvendelse af pattedyrcytokinrelaterede reagenser |
DE602004016522D1 (de) * | 2003-07-18 | 2008-10-23 | Schering Corp | Behandlung und diagnose von neoplasien mit tslp (thymic stromal lymphopoietin) |
US20050249712A1 (en) | 2004-03-23 | 2005-11-10 | The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services | Methods for use of TSLP and agonists and antagonists thereof |
CA2513350A1 (en) * | 2005-03-02 | 2006-09-02 | Sydney West Area Health Service | Treatment for multiple sclerosis |
GB0603683D0 (en) * | 2006-02-23 | 2006-04-05 | Novartis Ag | Organic compounds |
SE532251C2 (sv) * | 2006-11-28 | 2009-11-24 | Theravac Pharmaceuticals Ab | Nya formuleringar av TSLP för behandling av TH2-medierade inflammatoriska sjukdomar genom vaccinering |
BRPI0720001A2 (pt) * | 2006-12-14 | 2013-12-24 | Schering Plough Ltd | Proteína linfopoietin estromal tímica canina e usos da mesma |
KR20100034015A (ko) | 2007-06-20 | 2010-03-31 | 아이알엠 엘엘씨 | 알레르기 질환 치료를 위한 방법 및 조성물 |
KR20110067046A (ko) * | 2008-10-09 | 2011-06-20 | 더 리전츠 오브 더 유니버시티 오브 캘리포니아 | 발광 다이오드의 칩 형상화를 위한 광전기화학 식각 |
EP2213682A1 (en) | 2009-01-30 | 2010-08-04 | Institut Curie | TSLP promotes immune evasion and persistence of viruses |
AR082163A1 (es) | 2010-07-15 | 2012-11-14 | Hoffmann La Roche | Anticuerpos especificamente ligantes del tslpr humano y metodos de utilizacion de los mismos |
AR090915A1 (es) | 2012-05-04 | 2014-12-17 | Intervet Int Bv | Proteina de fusion de proteina linfopoyetina estromal timica canina con la region fc de igg |
LT3347377T (lt) | 2015-09-09 | 2021-05-25 | Novartis Ag | Užkrūčio liaukos stromos limfopoetiną (tslp) rišantys antikūnai ir antikūnų panaudojimo būdai |
US10000561B2 (en) | 2015-09-09 | 2018-06-19 | Novartis Ag | Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules |
BR112021014106A2 (pt) | 2019-01-22 | 2021-10-13 | Bristol-Myers Squibb Company | Anticorpos contra subunidade alfa de il-7r e usos dos mesmos |
MX2022009302A (es) * | 2020-02-03 | 2022-11-16 | Medikine Inc | Compuestos de unión a il-7r¿. |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2046920B1 (sl) | 1969-06-19 | 1974-05-03 | Citizen Watch Co Ltd | |
US3940475A (en) | 1970-06-11 | 1976-02-24 | Biological Developments, Inc. | Radioimmune method of assaying quantitatively for a hapten |
NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4036945A (en) | 1976-05-03 | 1977-07-19 | The Massachusetts General Hospital | Composition and method for determining the size and location of myocardial infarcts |
US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
US4331647A (en) | 1980-03-03 | 1982-05-25 | Goldenberg Milton David | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers |
US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
US4659678A (en) | 1982-09-29 | 1987-04-21 | Serono Diagnostics Limited | Immunoassay of antigens |
US4859609A (en) | 1986-04-30 | 1989-08-22 | Genentech, Inc. | Novel receptors for efficient determination of ligands and their antagonists or agonists |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5194375A (en) * | 1989-06-15 | 1993-03-16 | Immunex Corporation | Dna encoding interleukin-7 receptors and methods of use |
ATE149841T1 (de) | 1990-01-26 | 1997-03-15 | Immunomedics Inc | Impfstoffe gegen krebs und infektionskrankheiten |
US5789192A (en) | 1992-12-10 | 1998-08-04 | Schering Corporation | Mammalian receptors for interleukin-10 (IL-10) |
US6982320B2 (en) | 1998-03-19 | 2006-01-03 | Human Genome Sciences, Inc. | Cytokine receptor common gamma chain like |
AU3072799A (en) | 1998-03-19 | 1999-10-11 | Human Genome Sciences, Inc. | Cytokine receptor common gamma chain like |
US6861227B2 (en) * | 1998-03-19 | 2005-03-01 | Human Genome Sciences, Inc. | Antibodies to cytokine receptor common gamma chain like |
US6844170B1 (en) | 1998-03-19 | 2005-01-18 | Human Genome Sciences, Inc. | Cytokine receptor common gamma chain like |
EP2314696A1 (en) | 1998-09-21 | 2011-04-27 | Schering Corporation | Therapeutic uses of human Interleukin-B50 antagonist. |
US20030099947A1 (en) | 1998-09-21 | 2003-05-29 | Bazan J. Fernando | Mammalian cytokines; related reagents and methods |
DE69936105T3 (de) | 1998-11-13 | 2017-07-27 | Immunex Corporation | Menschliche tslp nukleinsäuren und polypeptide |
PT2077279E (pt) | 2000-06-28 | 2012-09-14 | Amgen Inc | Moléculas do receptor de linfopoietina estromal tímica e suas utilizações |
AU2001271624A1 (en) * | 2000-06-28 | 2002-01-08 | Whitehead Institute For Biomedical Research | Thymic stromal lymphopoietin receptor molecules and uses thereof |
US6890734B2 (en) * | 2000-11-10 | 2005-05-10 | Schering Corporation | Nucleic acids encoding a cytokine receptor complex |
WO2002068588A2 (en) | 2001-02-21 | 2002-09-06 | Human Genome Sciences, Inc. | Cytokine receptor common gamma chain like |
DK2311869T3 (da) | 2002-02-01 | 2013-03-18 | Merck Sharp & Dohme | Anvendelse af pattedyrcytokinrelaterede reagenser |
US7301144B2 (en) * | 2004-12-29 | 2007-11-27 | General Electric Company | Method and system for calibrating a positron emission tomography system |
US9729801B2 (en) | 2014-10-02 | 2017-08-08 | Dolby Laboratories Licensing Corporation | Blending images using mismatched source and display electro-optical transfer functions |
-
2001
- 2001-11-08 US US10/008,566 patent/US6890734B2/en not_active Expired - Lifetime
- 2001-11-09 EP EP10179981A patent/EP2292760A3/en not_active Withdrawn
- 2001-11-09 WO PCT/US2001/050351 patent/WO2002068646A2/en not_active Application Discontinuation
- 2001-11-09 DK DK01273862.1T patent/DK1379647T3/da active
- 2001-11-09 SI SI200131023T patent/SI1379647T1/sl unknown
- 2001-11-09 PT PT1273862T patent/PT1379647E/pt unknown
- 2001-11-09 EP EP01273862.1A patent/EP1379647B1/en not_active Revoked
- 2001-11-09 ES ES01273862T patent/ES2424126T3/es not_active Expired - Lifetime
-
2004
- 2004-08-25 US US10/927,228 patent/US7071308B2/en not_active Expired - Lifetime
-
2005
- 2005-12-09 US US11/297,957 patent/US7569224B2/en not_active Expired - Lifetime
-
2009
- 2009-06-29 US US12/493,871 patent/US8075886B2/en not_active Expired - Fee Related
-
2011
- 2011-11-02 US US13/287,456 patent/US20120177658A1/en not_active Abandoned
-
2013
- 2013-12-02 US US14/094,511 patent/US20140093875A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PT1379647E (pt) | 2013-09-05 |
US20050014199A1 (en) | 2005-01-20 |
US20060110386A1 (en) | 2006-05-25 |
WO2002068646A2 (en) | 2002-09-06 |
US20140093875A1 (en) | 2014-04-03 |
DK1379647T3 (da) | 2013-09-02 |
US8075886B2 (en) | 2011-12-13 |
US7569224B2 (en) | 2009-08-04 |
EP2292760A3 (en) | 2012-10-10 |
US6890734B2 (en) | 2005-05-10 |
ES2424126T3 (es) | 2013-09-27 |
US20120177658A1 (en) | 2012-07-12 |
US7071308B2 (en) | 2006-07-04 |
EP1379647B1 (en) | 2013-06-05 |
WO2002068646A3 (en) | 2003-11-06 |
US20090275135A1 (en) | 2009-11-05 |
EP1379647A2 (en) | 2004-01-14 |
US20020173623A1 (en) | 2002-11-21 |
EP2292760A2 (en) | 2011-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1379647T1 (sl) | Antagonist antiteles sesaläśevega citokina ali njegovega receptorja za zdravljenje alergije | |
HUP0303976A3 (en) | Combination therapy using anti-egfr antibodies and hormone antagonists | |
IL149701A0 (en) | Use of anti-ctla-4 antibodies | |
IL155805A0 (en) | Novel sulfamides and their use as endothelin receptor antagonists | |
IL156304A0 (en) | Cxcr3 antagonists | |
IL152700A0 (en) | Substituted 1-aminoalkyl-lactams and their use as muscarinc receptor antagonists | |
EP1254116A4 (en) | ALPHA V INTEGRIN RECEPTOR ANTAGONISTS | |
AU2002340167A8 (en) | Anti-hla-dr antibodies and the methods of using thereof | |
IL158701A0 (en) | Novel use of nk3 receptor antagonist | |
EP1252162A4 (en) | ALPHA V INTEGRIN RECEPTOR ANTAGONISTS | |
AU2003285540A8 (en) | Antibody for the thyrotropin receptor and uses thereof | |
EP1373508A4 (en) | HUMAN CYTOKIN RECEPTOR | |
HK1154504A1 (en) | Chemokine receptor antagonists and methods of use thereof | |
EP1178829A4 (en) | HUMAN MONOCLONAL ANTIBODY | |
EP1370676A4 (en) | CYTOKIN RECEPTOR FROM MOUSE | |
AU2001290772A1 (en) | Alpha v integrin receptor antagonists | |
IL198759A (en) | Use of 3gal receptor antagonists to prepare medications to treat depression and / or anxiety | |
AU9259801A (en) | Alpha v integrin receptor antagonists | |
EP1351687A4 (en) | UROTENSIN II RECEPTOR ANTAGONISTS | |
AU2002359524A8 (en) | P2x7 receptor antagonists | |
HK1047750A1 (zh) | 趨化因子受體拮抗劑 | |
EP1344823A4 (en) | NEW G-PROTEIN-COUPLED RECEPTOR PROTEINS AND THEIR DNAS | |
IL156087A0 (en) | Histamine receptor antagonists | |
PL370367A1 (en) | Ccr-3 receptor antagonists v | |
AU2002336782A8 (en) | Penis vibrator |